Cancer News: Esophageal
Lung and esophageal cancer survivors may not get benefit from radioactive imaging tests used to diagnose cancer recurrence, a new study reveals.
Pembrolizumab and nivolumab, two targeted immunotherapies, appeared effective in advanced gastric and esophageal cancers, two trials revealed.
Radiation therapy that targets only the involved lymph nodes regions results in less toxicity without affecting overall survival rates in esophageal cancer patients.
New research has shown that when patients with esophageal cancer are treated with proton therapy, a new type of treatment, they experience fewer side effects.
Patients with gastrointestinal stromal tumors may develop additional malignancies before and after their diagnosis, according to the first population-based study.
Taking aspirin regularly and for a long time may decrease the risk of gastrointestinal cancer. However, the potential risks of prolonged aspirin use should be considered.
A lung cancer drug was used in a trial against a type of esophageal cancer with EGFR gene duplication, and resulted in longer survival for those patients.
Got heartburn? More than 60 million adults in the U.S. have acid reflux, or heartburn, and approximately 10 percent are at risk for developing esophageal cancer, due in part to complications from Barrett's esophagus. But researchers at Rhode Island Hospital discovered a pathway they believe links Barrett's esophagus to the development of esophageal cancer. Their data suggest that blocking this pathway, such as with a proton pump inhibitor (e.g. omeprazole), may prevent the development of esophageal cancer. The study is published online in advance of print in the journal American Journal of Cell Physiology.
Cancer Research UK scientists show that while inherited faulty genes can increase the risk of Barrett’s Oesophagus – a condition linked to acid reflux – it may be lifestyle factors such as smoking and obesity that cause it to develop into oesophageal cancer – according to a major study published in Nature Genetics.
Israelis who were overweight as teenagers were more likely to have esophageal or gastroesophageal junction cancers later in life, researchers reported.
An international consortium co-led by researchers at Fred Hutchinson Cancer Research Center and the QIMR Berghofer Medical Research Institute in Australia has identified four genetic variants associated with an increased risk of esophageal cancer and its precursor, a condition called Barrett's esophagus.
Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida.
A new study published in the Journal 'Cancer' reveals that patients suffering from esophageal cancer may experience different "clusters" of symptoms months after surgery, and that patients with certain clusters may be at increased risk of death from the disease.
Even more esophageal cancer patients may benefit from chemotherapy before surgery to remove a tumor, compared to what was previously thought.
A biomarker for Esophageal Squamous Cell Carcinoma (ESCC) has been discovered, which can help diagnosis, prognosis and treatment of this disease.
Patients' quality of life recovers to normal levels 10 years after esophagectomy with gastric pull-up, a surgical procedure for treating esophageal cancer.
Radiofrequency ablation (use of heat applied through an endoscope to destroy cells) for Barrett esophagus reduced risk of this condition progressing to cancer.
Two validation studies show that a test can accurately predict response to chemoradiation therapy before surgery, in patients with esophageal adenocarcinoma.
A review showed radiofreqeuncy ablation & complete endoscopic resection to be equally effective against dysplastic Barrett's esophagus which may lead to cancer.
Statins, usually used to lower cholesterol, greatly reduce a patient's risk of developing Barrett's esophagus - a condition which may lead to esophageal cancer.
A new study shows that the traditional surgical resection for early-stage esophageal cancer provided significantly better outcomes than endoscopic resection.
New research reveals aspirin can significantly reduce the risk of developing and dying from digestive tract cancers: colon (bowel), stomach & esophageal cancer.